This email may be of interest to those dealing with MSA and DLB — both of which are disorders of the protein alpha-synuclein.
The American Academy of Neurology Annual Meeting took place in mid-April. Medscape is a medical information company. Two Medscape representatives met with the senior associate director of research programs at the Michael J. Fox Foundation for Parkinson’s Research. They discussed the latest in PD research. The part of the article on alpha-synuclein is of most interest to our MSA and DLB group members. (In fact, MSA is mentioned below – as “multi-system atrophy.”)
As this article is written for healthcare professionals, some of the text can be challenging. But I’m sure you’ll find it interesting to see where the research is focused now.
www.medscape.com/viewarticle/
(Most likely you need to have a Medscape account to access this webpage. As I recall, it’s free to open an account.)
Robin